NEW YORK (GenomeWeb News) – The Oxford Biomedical Research Centre will install several 454 GS FLX sequencing instruments and will use NimbleGen arrays to conduct genome-wide studies focused on finding links between human diseases and genetic mutations, 454 and NimbleGen parent company Roche said Thursday.
OxBRC is a partnership between Oxford Radcliffe Hospitals NHS Trust and the University of Oxford.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.